BWM
ABBV icon

Benchmark Wealth Management’s AbbVie ABBV Stock Holding History

Benchmark Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,021
Closed -$214K – 71
2025
Q1 		$214K Buy
+1,021
New +$198K 0.1% 64
2024
Q4 		– Sell
-1,021
Closed -$202K – 53
2024
Q3 		$202K Buy
+1,021
New +$191K 0.1% 54

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Benchmark Wealth Management's ABBV Position: Q2 2025 in Review

Benchmark Wealth Management sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,021 shares — an estimated $214K sold.

Benchmark Wealth Management first reported a position in ABBV in Q3 2024 and held it in 2 quarters. The position peaked at $214K in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Benchmark Wealth Management reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Benchmark Wealth Management sold 1,021 AbbVie shares in Q2 2025, an estimated $214K.
  • Benchmark Wealth Management first reported a position in AbbVie in Q3 2024 and held it in 2 quarters.
  • Benchmark Wealth Management's AbbVie position peaked at $214K in Q1 2025.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Benchmark Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.